Source:http://linkedlifedata.com/resource/pubmed/id/12667308
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2003-4-1
|
pubmed:abstractText |
25 patients with cancer of unknown primary (CUP) were studied using PET-FDG. Whole-body-PET scans were performed based on previous morphological information. All patients underwent conventional diagnostic modalities prior to and after the PET-study. True positive results were obtained in 12/25 patients (48%) and the primary identified by PET was confirmed by further procedures. True negative results were obtained in 8/25 patients (32%) and no primary tumor was found by PET or other clinical investigations. False positive results were obtained in 5/25 patients (20%). No false negative results were obtained. In 11 patients having CT compared with PET the primary tumor was exclusively localized by PET in 8 patients (73%) and also by CT in 3 patients (27%); CT was unable to identify the tumor in 8/11 patients detected by PET. PET affected management and directed treatment in 11/25 patients (44%). The sensitivity of PET-FDG was 100%, specificity 61%. These observations demonstrate that PET-FDG is a highly sensitive method to detect CUP. Correctly classified patients in an early stage of disease may lead to benefit from a more targeted therapy with prolonged survival time. In cases of advanced disease PET might not decisively influence survival time.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1084-9785
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
47-58
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12667308-Adult,
pubmed-meshheading:12667308-Aged,
pubmed-meshheading:12667308-Female,
pubmed-meshheading:12667308-Fluorodeoxyglucose F18,
pubmed-meshheading:12667308-Humans,
pubmed-meshheading:12667308-Male,
pubmed-meshheading:12667308-Middle Aged,
pubmed-meshheading:12667308-Neoplasms, Unknown Primary,
pubmed-meshheading:12667308-Tomography, Emission-Computed,
pubmed-meshheading:12667308-Tomography, X-Ray Computed
|
pubmed:year |
2003
|
pubmed:articleTitle |
PET with 2-[F-18]-fluoro-2-deoxy-D-glucose (FDG) in patients with cancer of unknown primary (CUP): influence on patients' diagnostic and therapeutic management.
|
pubmed:affiliation |
Department of Radiology, Clinic of Nuclear Medicine, Johann Wolfgang Goethe University of Frankfurt, Frankfurt, Germany. pmantaka@web.de
|
pubmed:publicationType |
Journal Article
|